Kindeva Drug Delivery (United States)

<p>In the originally published article titled “A Comprehensive Update on Nanotechnology in Functional Food Developments: Recent Updates, Challenges, and Future Perspectives”, published in “Recent Patents on Nanotechnology”, Vol: 19, Issue: 2, 2025 [1], certain phrases and expressions were unclear, which may have affected readability. These have now been revised to improve clarity and ensure that the intended meaning is accurately conveyed. The corrections do not affect the results, interpretations, or conclusions of the article. </p> <p> The original article can be found online at: https://www.benthamscience.com/article/134038 </p> <p> Details of the error and the correction are provided below: </p> <p> Original: </p> <p> Scientific statistics about the relationship between health and diet are also more readily available (heart sickness, diabetes, overweightness, and arthritis). </p> <p> Corrected: </p> <p> Scientific statistics about the relationship between health and diet are also more readily available (cardiovascular disorders, diabetes, overweight, and arthritis). </p> <p> The authors apologize for any inconvenience caused.</p>

To clarify the impact of systematic nursing on preventing lower limb deep venous thrombosis after obstetrics and gynaecology surgery. The study was conducted at the Nanjing Women and Children's Healthcare Hospital, Nanjing, China, from November 2020 to November 2022, and comprised women inpatients who had undergone caesarean section. The subjects were randomised into control group CG and observation group OG. CG subjects underwent conventional nursing, while OG subjects received systematic nursing intervention, including preoperative, intraoperative and postoperative nursing. Negative emotions, nursing satisfaction, complication incidence and lower limb status were compared between the groups. Data was analysed using SPSS 27. Of the 100 subjects, 50(50%) women were in CG group with mean age 29.41±1.34 years, while 50(50%) were in OG group with mean age 29.55±1.35 years. Post-intervention, negative emotion scores were lower, nursing satisfaction scores were higher, the incidences of lower limb deep venous thrombosis and pulmonary embolism were fewer, and the scores of lower limb status were lower in OG group compared to CG (p<0.05). The application of systematic nursing intervention in obstetrics and gynaecology patients undergoing surgery could effectively prevent lower limb deep venous thrombosis, reduce the incidence of pulmonary embolism, improve patients' lower limb status and negative emotions, and increase satisfaction level with nursing.

This study develops a visible-light-driven, metal-free photocatalytic strategy that utilizes silicate reagents to generate reactive silicon-centered radicals. These radicals undergo efficient addition to olefins followed by strain-driven cyclization,

A surfactant is often present in a pharmaceutical formulationandcan accelerate the crystallization of the active component. We investigatethe effects of two common surfactants with different hydrophilic–lipophilicbalance, Span 80 and Tween 80, on the crystallization of posaconazole(POS) in its two polymorphic forms (I and II). At 0–10 wt %,the two surfactants similarly increase the growth rates of both polymorphs,but have different effects on their nucleation rates, without exhibitingthe proportional-modification behavior observed for many other amorphoussystems. The classical nucleation theory (CNT) can quantitativelydescribe the nucleation kinetics in the pure POS melt and in the surfactant-dopedmelts, where the surfactants are treated as ideal diluents of POS.The two surfactants’ effects on the nucleation rate form asingle trend in the CNT analysis, yielding the nucleus/liquid interfacialtension σ = 0.019 J/m2 for Form I and 0.012 J/m2 for Form II. The σ value of 0.019 J/m2 forForm I nucleating from a doped melt exceeds that for nucleating froma pure melt (0.012 J/m2), possibly reflecting a greaterstructural difference between a chemically pure crystal and an impuremelt. This work has provided a strong test of the CNT by applyingit to both pure and doped melts where the crystallization drivingforce is varied through temperature in the pure system and throughconcentration in the doped system, and yielded a simple picture fortwo chemically distinct surfactants on the crystallization in a polymorphicsystem.

The objective of this study was to fabricate a chitosan based thermosensitive in situ gel containing riluzole nanosuspension (RLZ-NS) for intranasal drug delivery to the brain. Accordingly, RLZ-NS was produced using anti-solvent crystallization method and optimized based on saturation solubility (Cs), particle size (PS), polydispersity index (PDI), zeta potential (ZP), and dissolution efficiency percentage after 90 minutes (DE90 min%). An I-optimal response surface methodology design was then used to evaluate the impact of the anti-solvent/solvent volume ratio, polymer content and polymer type on these variables. The optimal formulation was then incorporated into a thermosensitive chitosan–β-glycerophosphate hydrogel (RLZ-NS-Hydrogel) and subjected to various evaluations including pH, gelation time, in vitro release, and histopathological tests. The therapeutic efficacy of the optimal RLZ-NS-Hydrogel was tested using the behavioral models of depression in mice. The optimal formulation exhibited a Cs of 683.64 ± 31.14 µg/ml, a PS of 398.70 ± 10.56 nm, a PDI of 0.38 ± 0.01, a ZP of −20.35 ± 2.33 mV, and DE90 min% of 69.23 ± 0.97%. Scanning electron microscopy also revealed that RLZ-NS had a spherical shape. Further, the histopathological effects in sheep nasal mucosa showed that RLZ-NS-Hydrogel had no significant impact on the microscopic structure of mucosa and could be safe for nasal administration. Intranasal administration of RLZ-NS-Hydrogel also produced an antidepressant-like effect comparable to intraperitoneal RLZ in mice, and it was increased, as compared to oral RLZ and intranasal RLZ-Hydrogel. In conclusion, RLZ-NS-Hydrogel showed a potential for nose to brain delivery in treatment of depression.

Over the past few years, some work has been done to develop a curriculum for teaching quantum technicians. One challenge centers on the concept that there are multiple fundamentally different technologies involved in many of the applications. These include different approaches to quantum computing, communications, and sensing. Technician training, like for laser and optics technicians, typically have been completed in two years or less at local community colleges, with associate degrees being the top-level credential available. Other shorter programs lead to certificates in the specific area of training. An umbrella concept that emerged from a QED-C workshop three was that creating awareness of introductory quantum topics for students in adjacent technology programs, like lasers, optics, nano, and microelectronics could be implemented by adding one or more quantum courses to these programs, based on the requirements of local industry, academic and government laboratory needs. Continuing to build on these efforts, this paper highlights some details of a few programs as examples to provide models for other programs to use in their local communities. One key concept addressed is how to recruit students to these programs from the local communities and recommendations to help guide program development for new entrants to the field.

Microneedle Array Patches (MAPs) are an emerging dosage form that creates transient micron-sized disruptions in the outermost physical skin barrier, the stratum corneum, to facilitate delivery of active pharmaceutical ingredients to the underlying tissue. Numerous MAP products are proposed and there is significant clinical potential in priority areas such as vaccination. However, since their inception scientists have hypothesized about the risk of a clinically significant MAP-induced infection.Safety data from two major Phase 3 clinical trials involving hundreds of participants, who in total received tens of thousands of MAP applications, does not identify any clinically significant infections. However, the incumbent data set is not extensive enough to make definitive generalizable conclusions. A comprehensive assessment of the infection risk is therefore advised for MAP products, and this should be informed by clinical and pre-clinical data, theoretical analysis and informed opinions.In this article, a group of key stakeholders identify some of the key product- and patient-specific factors that may contribute to the risk of infection from a MAP product and provide expert opinions in the context of guidance from regulatory authorities. Considerations that are particularly pertinent to the MAP dosage form include the specifications of the finished product (e.g. microbial specification), it's design features, the setting for administration, the skill of the administrator, the anatomical application site, the target population and the clinical context. These factors, and others discussed in this article, provide a platform for the development of MAP risk assessments and a stimulus for early and open dialogue between developers, regulatory authorities and other key stakeholders, to expedite and promote development of safe and effective MAP products.